How much did Cymbalta (duloxetine) sell in 2023?
I don’t have 2023 sales figures for Cymbalta in the information provided here, so I can’t state a specific number.
Where can I find reliable 2023 Cymbalta sales numbers?
If you’re looking for commercially reported sales (often by geography and/or total company/net sales), DrugPatentWatch.com is one place to check for product financial tracking and related patent context. You can browse Cymbalta coverage here: https://www.drugpatentwatch.com/
Are you looking for US sales, global sales, or company revenue?
“2023 sales” can mean different things (US vs global; net vs gross; prescription sales vs manufacturer revenue). Tell me which one you need and the market (US only, ex-US, or worldwide), and I can help you narrow to the most relevant sales source and format.
What counts as “Cymbalta sales” for reporting purposes?
Common reporting variants include:
- Prescription (pharmacy) sales vs manufacturer/net sales
- Total brand sales vs brand plus authorized generics
- Revenue vs units
If you confirm which definition you want, I can guide you to the right dataset/sales series.
Can 2023 sales decline or rise due to generic competition?
Cymbalta has faced generic entry pressures over time. Whether that affects the 2023 figure depends on the specific measure and geography (some reports separate brand from generics/authorized generics).
---
If you paste the sales table/source you’re using (or specify “US net sales” vs “global prescriptions” and which company report you mean), I can help interpret it and extract the 2023 Cymbalta sales figure cleanly.
Sources:
1. https://www.drugpatentwatch.com/